The National Pharmaceutical Council’s (NPC) fourth annual survey of health care stakeholders is... Watch Video
NPC at a Glance
NPC is a health policy research organization focused on the critical issues of evidence, the value of medicines for patients, and innovation...more
CER
Do stakeholders think comparative effectiveness research is having an impact on health care decision making? Which organizations are viewed as the leaders on prioritizing, funding, and conducting research? Download our new booklet to find out...more
Value of Rx
Recent NPC research has focused on defining the optimal role and value of pharmaceuticals in the evolving payment and delivery models...more
Individual Treatment Effects
Being "unique" can impact your health care treatments. Learn more about the challenges of individual treatment effects...more
RECENT NEWS
PCORI Grants, HEOR & FDA Guidance Top CER Tweets of the Week (July 21-25)
What were some of the popular comparative effectiveness research (CER)-related topics on Twitter this week? We... more
NPC Study Outlines When & How Health Decision-Makers Should Consider Individual Patient Differences
Washington, DC (July 29, 2014)—New research led by the National Pharmaceutical Council (NPC) can assist health... more
E.V.I.dently July 2014
NPC MessageWhen & How Health Decision-Makers Should Consider Individual Patient DifferencesBy Jennifer S.... more#TBT: Expanding Your Horizons: CER Continuing Education Certificate Program
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and... more
PCORI Works on Funding Announcements, Research Portfolio and Standards in July
The Patient-Centered Outcomes Research Institute (PCORI) has remained active throughout July, hosting two Board... moreConsumer-Directed Health Plans: Pharmacy Benefits & Best Practices
A unique survey of large employers sheds light on the strategies and best practices that they follow when... moreCMS Issues Two Proposed Rules on Payments, Quality Measures
Earlier this month, the Centers for Medicare and Medicaid Services (CMS) issued two proposed rules to update... moreWorkers Welcome Wellness Programs, But Not at the Expense of Low Premiums
Employees are happy to participate in workplace wellness programs, but they don’t think it’s appropriate to be... moreNPC Study Outlines When & How Health Decision-Makers Should Consider Individual Patient Differences
Washington, DC (July 29, 2014)—New research led by the National Pharmaceutical Council (NPC) can assist health... moreSpecialty Medications: Shifting the Focus From “How Much” We Spend to “How Well” We Spend
Washington, DC, June 9, 2014—As health care decision-makers grapple with how to ensure access to specialty... moreNPC Annual Stakeholder Survey: Comparative Effectiveness Research Is Important, But Impact on Health Care Decision-Making Is Still on the Horizon
(Washington, DC, May 19, 2014)—A new survey of health care stakeholders reveals continued optimism for the use... moreCER Collaborative Improving Health Outcomes Through New Comparative Evidence Tools
(Washington, DC, March 24, 2014)—Three peer-reviewed articles published in Value in Health offer important... more
Healthcare Leadership Council & NPC Submit Comments to CMS on Access to Part D Data
March 7, 2014The Honorable Marilyn Tavenner, AdministratorCenters for Medicare & Medicaid ServicesU.S.... moreNPC Comments on CMS' Proposed Changes to Protected Classes
March 7, 2014Marilyn B. TavennerAdministratorCenters for Medicare & Medicaid ServicesU.S. Department of... moreThe State of CER and the Environment for Health Care Decision Making
This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (... moreKeeping Our Eye on the CER Ball
Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington... more
Consumer-Directed Health Plans
A unique survey of large employers sheds light on the strategies and best practices that they follow when... moreIncorporating Patient Views Into Health Technology Assessments
David Grainger, senior director, global public policy, Eli Lilly and Company, explains that many health... moreHealth Technology Assessments and Specialty Medications
David Grainger, senior director, global public policy, Eli Lilly and Company, says that there are often... moreDifferences in Global Health Technology Assessment
David Grainger, senior director, global public policy, Eli Lilly and Company, describes how health technology... morePCORI Grants, HEOR & FDA Guidance Top CER Tweets of the Week (July 21-25)
What were some of the popular comparative effectiveness research (CER)-related topics on Twitter this week? We... more#TBT: Expanding Your Horizons: CER Continuing Education Certificate Program
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and... moreCER Tweets of the Week: Improving Patient Care Remains Hot Topic (July 14 - 18)
Evidence-based medicine (EBM) and the role of big data in improving patient care continued to be hot topics... moreCER Tweets of the Week: Patient-Generated Data, Value-Based Payment Programs & Impact of CER (July 7 - 11)
Which issues attracted comparative effectiveness research (CER) stakeholders’ attention this week in the ... moreNEWS FEEDS
EVENT
Mind the Gap: Improving Quality Measurement
Join us on October 30 to examine the use of quality measures to balance financial incentives in accountable care systems, gaps in accountable care measure sets, and possible solutions for addressing these gaps.
October 30, 2014
10 am – 3:15 pm ET
NEWS
CER Is Important, But Impact Is Still on the Horizon
“The survey provides an important look at how perceptions of CER have shifted during the implementation of the Affordable Care Act.” —NPC Director of Health Services Research Kimberly Westrich
